| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |